Who makes GLPG0555 solid dispersion?

GLPG0555 solid dispersion is developed by Galapagos NV.

What development phase is GLPG0555 solid dispersion in?

GLPG0555 solid dispersion is in Phase 1.

Last reviewed 2026-04-19 · How we verify

GLPG0555 solid dispersion

Galapagos NV · Phase 1 active Small molecule

At a glance

Generic name	GLPG0555 solid dispersion
Sponsor	Galapagos NV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Oral Bioavailability of GLPG0555 in Different Solid Formulations (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GLPG0555 solid dispersion CI brief — competitive landscape report
GLPG0555 solid dispersion updates RSS · CI watch RSS
Galapagos NV portfolio CI